Release Date: 31/03/14 10:34 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 161.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%